Bring your light for the World Duchenne Awareness Day 2019
Italfarmaco is devoted to bring the light of hope into the world of Duchenne by committing to develop drugs to slow down the disease progression...
TRiNDS and Italfarmaco Announce US Patient Advocacy Partnership for EPIDYS Trial of Givinostat for Duchenne Muscular Dystrophy
Pittsburgh, PA, November 9, 2018 - Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS), a specialty contract research organization, and Italfarmaco SpA, a privately held [...]
World Duchenne Awareness Day 2018
Italfarmaco committed to its mission to contribute to the improvement of the quality and the prolongation of human lifespan, is proud to support the [...]
Acquisition of Effik, S.A.
Italfarmaco Group announces the acquisition of the remaining 50% of Effik, S.A.